Correction: Folate metabolism-associated CYP26A1 is a clinico-immune target in colorectal cancer
Year: 2026
Type: erratum
Abstract: During a recent internal review of our previously published work—conducted as part of preparations for the next phase of our research—we identified an unintentional duplication in Figure 9H, specifically in the RKO cell line Transwell and Matrigel panels between the shCYP26A1-1 and shCYP26A1-2 groups. This duplication was due to a clerical error during figure assembly, rather than data repetition or manipulation. In the interest of scientific accuracy and transparency, and out of respect for our readers, we have made the following corrections and provided the associated materials.
Source: Genes and Immunity
Authors: Yifei Zhu, Teng Zhou, Yao Zheng, Yanxi Yao, Mingxi Lin, Cheng Zeng, Yuxin Yan, Yifei Zhou, Dou-Dou Li, Jian Zhang
Institutions: Shanghai Medical College of Fudan University, Fudan University, Fudan University Shanghai Cancer Center, Chinese Academy of Sciences, Center for Excellence in Molecular Cell Science, University of Chinese Academy of Sciences, Tongji University, Shanghai Pulmonary Hospital, Shanghai University of Medicine and Health Sciences
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,190
OpenAlex ID: W7128488844
Cites:
Cited by:
Related to: